{"abstract": "The Carlyle Group and Hellman & Friedman agreed to buy Pharmaceutical Product Development in one of the largest private equity deals this year.", "web_url": "https://dealbook.nytimes.com/2011/10/03/carlyle-and-hellman-friedman-to-buy-ppd-for-3-9-billion/", "snippet": "The Carlyle Group and Hellman & Friedman agreed to buy Pharmaceutical Product Development in one of the largest private equity deals this year.", "lead_paragraph": "7:02 p.m. | Updated ", "source": "The New York Times", "multimedia": [], "headline": {"main": "Buyout Firms to Buy Drug Research Company for $3.9 Billion", "kicker": "DealBook", "content_kicker": null, "print_headline": "", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "subject", "value": "Mergers, Acquisitions and Divestitures", "rank": 1, "major": "N"}, {"name": "subject", "value": "Private Equity", "rank": 2, "major": "N"}, {"name": "organizations", "value": "Carlyle Group", "rank": 3, "major": "N"}, {"name": "organizations", "value": "HELLMAN & FRIEDMAN", "rank": 4, "major": "N"}, {"name": "organizations", "value": "Pharmaceutical Product Development", "rank": 5, "major": "N"}], "pub_date": "2011-10-03T13:20:01+0000", "document_type": "article", "news_desk": "", "section_name": "Business Day", "byline": {"original": "By Peter Lattman", "person": [{"firstname": "Peter", "middlename": null, "lastname": "Lattman", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/242ee431-39f9-5a49-8b46-802981ce2d25", "word_count": 498, "uri": "nyt://article/242ee431-39f9-5a49-8b46-802981ce2d25"}